The company currently has an FDA-cleared cardiac MRI platform but is looking to further its reach into other anatomies, such as the brain, prostate and spine.
Experts recently have become more interested in measurements of strain as predictive markers of adverse cardiac outcomes in the general population and across several pathologies.
“This study affirms that when interventional radiologists are afforded the time to evaluate and follow their patients, the complexity and value of the care they provide increases," one expert notes.
Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.